Nature Communications (Jun 2023)

Elevated levels of FMRP-target MAP1B impair human and mouse neuronal development and mouse social behaviors via autophagy pathway

  • Yu Guo,
  • Minjie Shen,
  • Qiping Dong,
  • Natasha M. Méndez-Albelo,
  • Sabrina X. Huang,
  • Carissa L. Sirois,
  • Jonathan Le,
  • Meng Li,
  • Ezra D. Jarzembowski,
  • Keegan A. Schoeller,
  • Michael E. Stockton,
  • Vanessa L. Horner,
  • André M. M. Sousa,
  • Yu Gao,
  • Birth Defects Research Laboratory,
  • Jon E. Levine,
  • Daifeng Wang,
  • Qiang Chang,
  • Xinyu Zhao

DOI
https://doi.org/10.1038/s41467-023-39337-0
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 23

Abstract

Read online

Abstract Fragile X messenger ribonucleoprotein 1 protein (FMRP) binds many mRNA targets in the brain. The contribution of these targets to fragile X syndrome (FXS) and related autism spectrum disorder (ASD) remains unclear. Here, we show that FMRP deficiency leads to elevated microtubule-associated protein 1B (MAP1B) in developing human and non-human primate cortical neurons. Targeted MAP1B gene activation in healthy human neurons or MAP1B gene triplication in ASD patient-derived neurons inhibit morphological and physiological maturation. Activation of Map1b in adult male mouse prefrontal cortex excitatory neurons impairs social behaviors. We show that elevated MAP1B sequesters components of autophagy and reduces autophagosome formation. Both MAP1B knockdown and autophagy activation rescue deficits of both ASD and FXS patients’ neurons and FMRP-deficient neurons in ex vivo human brain tissue. Our study demonstrates conserved FMRP regulation of MAP1B in primate neurons and establishes a causal link between MAP1B elevation and deficits of FXS and ASD.